Optimal Dosing of Breast Cancer Chemotherapy Using Robust MPC Based on Linear Matrix Inequalities
In this paper, we consider an application of robust model predictive control to optimal dosing of breast cancer chemotherapy. The model-patient mismatch is handled by computing an ellipsoidal invariant set containing the measured patient's states at each sampling time. An optimal dose of chemotherapeutic agent is obtained by solving a convex optimization problem subject to linear matrix inequalities. In the case study of simulated patients, the results show that the tumor volume can be reduced to a specified target with up to 30% model-patient mismatch. Moreover, the robust model predictive control algorithm can achieve better treatment results as compared with the nonlinear model predictive control algorithm while the on-line computational time is significantly reduced.
Authors who publish with Engineering Journal agree to transfer all copyright rights in and to the above work to the Engineering Journal (EJ)'s Editorial Board so that EJ's Editorial Board shall have the right to publish the work for nonprofit use in any media or form. In return, authors retain: (1) all proprietary rights other than copyright; (2) re-use of all or part of the above paper in their other work; (3) right to reproduce or authorize others to reproduce the above paper for authors' personal use or for company use if the source and EJ's copyright notice is indicated, and if the reproduction is not made for the purpose of sale.